Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Operating Expenses | 3,740 | 3,830 | 3,220 | 3,520 | 5,950 |
| Operating Income | -3,740 | -3,830 | -3,220 | -3,520 | -5,950 |
| Interest Expense | 20 | 20 | 20 | 480 | 510 |
| Other Income | -10 | 0 | 0 | -1,190 | 20 |
| Pre-tax Income | -3,770 | -3,850 | -3,240 | -5,190 | -6,440 |
| Net Income Continuous | -3,771 | -3,858 | -3,246 | -5,167 | -6,449 |
| Net Income | $-3,771 | $-3,858 | $-3,246 | $-5,167 | $-6,449 |
| EPS Basic Total Ops | -2.40 | -2.80 | -2.40 | -4.40 | -5.20 |
| EPS Basic Continuous Ops | -2.52 | -2.59 | -2.40 | -4.27 | -5.35 |
| EPS Diluted Total Ops | -2.40 | -2.80 | -2.40 | -4.40 | -5.20 |
| EPS Diluted Continuous Ops | -2.52 | -2.59 | -2.40 | -4.27 | -5.35 |
| EBITDA(a) | $-3,430 | $-3,510 | $-2,890 | $-2,870 | $-5,280 |